A carregar...

Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics

With the demographic shift of the global population toward longer life expectancy, the number of people living with Alzheimer’s disease (AD) has rapidly expanded and is projected to triple by the year 2050. Current treatments provide symptomatic relief but do not affect the underlying pathology of t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurol
Main Authors: Ritter, Aaron, Cummings, Jeffrey
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4553391/
https://ncbi.nlm.nih.gov/pubmed/26379620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2015.00186
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!